ALS Translational Research Program
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• 18 years of age or older
• Can communicate in written English
• Has a diagnosis of ALS/MND or is a known carrier of an ALS associated mutation
Locations
United States
Massachusetts
ALS Therapy Development Institute
RECRUITING
Watertown
Contact Information
Primary
Alan S Premasiri, M.S.
apremasiri@als.net
617-441-7200
Backup
Beth Levine
blevine@als.net
617-441-7200
Time Frame
Start Date: 2014-09-12
Estimated Completion Date: 2035-01-31
Participants
Target number of participants: 2000
Treatments
Person living with ALS/MND
An adult over the age of 18, that has received a diagnosis of ALS or other Motor Neuron Disease from a practicing physician.
Asymptomatic gene carrier
An adult over the age of 18 who does not have symptoms of ALS and carries a mutation known to be associated with ALS
Healthy Volunteer
An adult over the age of 18 who does not have any biological connection to ALS or other Motor Neuron Disease, and no significant health problems.
Related Therapeutic Areas
Sponsors
Leads: ALS Therapy Development Institute